Verastem (VSTM) analyst forecast and price target
Analyst forecast
Consensus of 9 analyst ratings
Based on 6 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Mizuho | Maintained | Outperform | $13.00 from $14.00 | Aug 11, 2026 |
| Guggenheim | Maintained | Buy | $12.00 from $14.00 | Aug 7, 2026 |
| RBC Capital | Maintained | Outperform | $14.00 from $15.00 | Jul 7, 2026 |
| BTIG | Maintained | Buy | $18.00 | Jul 2, 2026 |
| BTIG | Maintained | Buy | $18.00 | Jun 24, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 | Jun 24, 2026 |
| Jefferies | Maintained | Buy | $8.00 from $15.00 | Jun 23, 2026 |
| Mizuho | Maintained | Outperform | $14.00 from $16.00 | May 14, 2026 |
| BTIG | Maintained | Buy | $18.00 from $19.00 | May 8, 2026 |
| BTIG | Maintained | Buy | $19.00 | Apr 23, 2026 |
| BTIG | Maintained | Buy | $19.00 | Apr 20, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 | Apr 10, 2026 |
| BTIG | Maintained | Buy | $19.00 | Apr 10, 2026 |
| Jefferies | Initiated Coverage | Buy | $15.00 from $19.00 | Mar 30, 2026 |
| BTIG | Initiated Coverage | Buy | $19.00 | Mar 12, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $18.00 | Feb 4, 2026 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | — | Oct 16, 2025 |
| BTIG | Maintained | Buy | $20.00 | Sep 9, 2025 |
| RBC Capital | Maintained | Outperform | $13.00 from $12.00 | Aug 8, 2025 |
| RBC Capital | Maintained | Outperform | $12.00 from $16.00 | Jun 25, 2025 |
Frequently asked questions
What is the price target for VSTM stock?
The average 12-month analyst price target for Verastem (VSTM) is $13.83, with a high estimate of $18.00 and a low of $8.00, across 6 analysts.
Is VSTM a buy, sell, or hold?
Analysts covering Verastem currently average a Buy rating: 9 buy, 0 hold and 0 sell, from 9 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for VSTM?
The average price target of $13.83 implies 91.60% upside from the last price of $7.22.
What is the latest analyst rating on VSTM?
On Aug 11, 2026, Mizuho maintained Verastem at Outperform with a price target of $13.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.